Medicon to help build clinical research infrastructure in South Africa  

2006.03.17
Denmark's Medicon is collaborating with Aeras Global TB Vaccine Foundation, to help build a clinical research infrastructure in South Africa to pave the way for large scale Phase III TB vaccine trials in 2007

Medicon, a Danish drug development company, is collaborating with Aeras Global TB Vaccine Foundation, to help build a clinical research infrastructure in South Africa to pave the way for large scale Phase III TB vaccine trials in 2007. Aeras Global TB Vaccine Foundation is an international NGO funded by the Bill & Melinda Gates Foundation and the US Centers for Disease Control and Prevention.

The tasks Medicon is carrying out are part of a larger tuberculosis project that Denmark is involved in with Aeras Global TB Vaccine Foundation. Invest in Denmark and Copenhagen Capacity helped attract the project to Denmark in 2005. The first contact between Aeras and the two Danish organisations was established in New York in 2003, when representatives from Invest in Denmark and Copenhagen Capacity met the CEO of Aeras, Jerald Sadoff.

Medicon will help train up to 9,000 South Africans to conduct large clinical research for testing a TB vaccine which Statens Serum Institut, a Danish state owned organisation engaged in prevention and control of infectious diseases, is developing and producing according to an agreement with Aeras.

Gitte Pedersen of Invest in Denmark says: "The project will bring Denmark into the world vaccine elite. Denmark already has significant competencies in both the public and private sector in research, development and production of vaccines." The news was published by regional newspaper Frederiksborg Amts Avis.

Link > Medicon 

Link > Aeras 

Link > Statens Serum Institut

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×